World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 54 3862 3561 28 24 179 13230

Gal Markel publications per year

The chart shows the history of publications by Gal Markel between 2001 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Gal Markel published across 25 years, from 2001 to 2025, averaging 14.3 papers a year. Output peaked at 128 publications in 2023. 55 of the 357 publications appeared in the last two years.

No. of publications
25 50 75 100 125
Bar chart. Horizontal axis: year, 2001 to 2025. Vertical axis: number of publications, 0 to 128. Peak 128 publications in 2023. 2001: 1 publication 2002: 3 publications 2003: 4 publications 2004: 6 publications 2005: 3 publications 2006: 2 publications 2007: 8 publications 2008: 11 publications 2009: 8 publications 2010: 11 publications 2011: 8 publications 2012: 7 publications 2013: 11 publications 2014: 10 publications 2015: 8 publications 2016: 9 publications 2017: 8 publications 2018: 9 publications 2019: 11 publications 2020: 13 publications 2021: 14 publications 2022: 9 publications 2023: 128 publications 2024: 38 publications 2025: 17 publications
2001 2025

357 publications in total across all disciplines

View publications per year as a table
Gal Markel: publications per year, 2001 to 2025
Year Publications
2001 1
2002 3
2003 4
2004 6
2005 3
2006 2
2007 8
2008 11
2009 8
2010 11
2011 8
2012 7
2013 11
2014 10
2015 8
2016 9
2017 8
2018 9
2019 11
2020 13
2021 14
2022 9
2023 128
2024 38
2025 17
Total 357
Download as CSV

Gal Markel publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gal Markel sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 172–181 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 179 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181 179
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Gal Markel D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gal Markel sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 54–55 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155 54
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Gal Markel is affiliated with Tel Aviv University in Israel and has a research focus primarily in medicine and biochemistry, genetics, and molecular biology. Their work spans several subfields including oncology, molecular biology, immunology, pulmonary and respiratory medicine, and statistics and probability.

The scientist's research topics include:

  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Health Systems, Economic Evaluations, Quality of Life
  • Melanoma and MAPK Pathways
  • Immune Cell Function and Interaction
  • Statistical Methods in Clinical Trials

Gal Markel has contributed to numerous publications, with a strong presence in well-known scientific journals and venues. Their frequent publication venues include:

  • The Lancet Oncology
  • Cancers
  • JAMA Network Open
  • Journal for ImmunoTherapy of Cancer
  • Bioinformatics

Some recent scientific papers by Gal Markel are:

  • Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients, 2020, Science
  • MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma, 2020, OncoImmunology
  • Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma, 2020, Cancers
  • Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma, 2022, JAMA Network Open
  • Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy, 2021, Journal for ImmunoTherapy of Cancer

Gal Markel has collaborated extensively with several co-authors, reflecting a network of frequent scientific partnerships. These frequent co-authors include:

  • Tomer Meirson
  • David Bomze
  • Nethanel Asher
  • Jacob Schachter
  • Ronnie Shapira-Frommer

Best Publications

  • Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

    Erez N. Baruch;Erez N. Baruch;Ilan Youngster;Guy Ben-Betzalel;Rona Ortenberg

  • Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

    Chamutal Gur;Yara Ibrahim;Batya Isaacson;Rachel Yamin

  • Characterization of the expression of MHC proteins in human embryonic stem cells

    Micha Drukker;Gil Katz;Achia Urbach;Maya Schuldiner

  • Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients

    Michal J. Besser;Ronnie Shapira-Frommer;Avraham J. Treves;Dov Zippel

  • Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

    Tal I Arnon;Hagit Achdout;Ofer Levi;Gal Markel

  • Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies

    Michal J. Besser;Ronnie Shapira-Frommer;Orit Itzhaki;Avraham J. Treves

  • CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells.

    Jacob Hanna;Ori Wald;Debra Goldman-Wohl;Diana Prus

  • Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence

    Michal Harel;Rona Ortenberg;Rona Ortenberg;Siva Karthik Varanasi;Kailash Chandra Mangalhara

  • Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis

    Einav Shoshan;Aaron K. Mobley;Russell R. Braeuer;Takafumi Kamiya

  • Tumor and viral recognition by natural killer cells receptors.

    Tal I. Arnon;Gal Markel;Ofer Mandelboim

  • CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.

    Gal Markel;Niva Lieberman;Gil Katz;Tal I. Arnon

  • Establishment and large-scale expansion of minimally cultured young tumor infiltrating lymphocytes for adoptive transfer therapy

    Orit Itzhaki;Einat Hovav;Yaara Ziporen;Daphna Levy

  • Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease

    Hamzah Abu-Sbeih;David M. Faleck;Biagio Ricciuti;Biagio Ricciuti;Robin B. Mendelsohn

  • MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth

    Yael Nemlich;Eyal Greenberg;Eyal Greenberg;Rona Ortenberg;Rona Ortenberg;Michal J. Besser

  • Complexes of HLA-G Protein on the Cell Surface Are Important for Leukocyte Ig-Like Receptor-1 Function

    Tsufit Gonen-Gross;Hagit Achdout;Roi Gazit;Jacob Hanna

  • Triage and management of pericardial effusion.

    Massimo Imazio;Bongani M Mayosi;Antonio Brucato;Gal Markel

  • Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitors.

    Merav Lidar;Merav Lidar;Eitan Giat;Daniela Garelick;Yuval Horowitz

  • Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients.

    Michal J. Besser;Ronnie Shapira-Frommer;Avraham J. Treves;Dov Zippel

  • MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma

    Ricardo A. de Azevedo;Ricardo A. de Azevedo;Einav Shoshan;Shanzhi Whang;Gal Markel

  • Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions

    Gal Markel;Dana Wolf;Jacob Hanna;Roi Gazit

  • Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.

    Noam Stern;Gal Markel;Tal I. Arnon;Raizy Gruda

Frequent Co-Authors

Jacob Schachter
Jacob Schachter Sheba Medical Center
Ofer Mandelboim
Ofer Mandelboim Hebrew University of Jerusalem
Iris Barshack
Iris Barshack Sheba Medical Center
Jacob H. Hanna
Jacob H. Hanna Weizmann Institute of Science
Richard S. Blumberg
Richard S. Blumberg Brigham and Women's Hospital
Arnon Nagler
Arnon Nagler Sheba Medical Center
Angel Porgador
Angel Porgador Ben-Gurion University of the Negev
Gideon Rechavi
Gideon Rechavi Sheba Medical Center
Dana G. Wolf
Dana G. Wolf Hebrew University of Jerusalem
Omry Koren
Omry Koren Bar-Ilan University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare careers often require foundational nursing education. Many students explore options like accelerated RN to NP programs to fast-track their progression into advanced nursing roles that intersect with immunological sciences.

If you’re starting fresh without a nursing background, consider 12-month accelerated nursing programs online for non nurses. These intensive programs equip students with essential nursing skills in a condensed timeframe, making a nursing career more accessible while supporting future specialization.

For undergraduate students aiming to enter nursing quickly, the easiest ABSN programs to get into offer a streamlined path to earning a Bachelor of Science in Nursing. These programs balance accessibility with quality education, an excellent step before advancing to immunology-focused roles.

Additionally, for those seeking entry-level nursing positions, easy LPN programs to get into provide practical training and quick certification. This can serve as a stepping stone to more specialized healthcare careers connected to immunology.

Best Scientists Citing Gal Markel

Trending Scientists

Recently Published Articles